S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
BREAKING: Tiny biotech successfully treats blindness (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
BREAKING: Tiny biotech successfully treats blindness (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
BREAKING: Tiny biotech successfully treats blindness (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
BREAKING: Tiny biotech successfully treats blindness (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
NASDAQ:VALU

Value Line (VALU) Competitors

$46.61
+0.38 (+0.82%)
(As of 09/22/2023 ET)
Compare
Today's Range
$46.61
▼
$46.61
50-Day Range
$45.00
▼
$57.50
52-Week Range
$42.02
▼
$79.50
Volume
958 shs
Average Volume
3,033 shs
Market Capitalization
$439.53 million
P/E Ratio
23.78
Dividend Yield
2.40%
Price Target
N/A
ProfileChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

VALU vs. ABL, FDUS, DHIL, BRDG, SAR, VINP, SAMG, MRCC, SCU, and BANX

Should you be buying Value Line stock or one of its competitors? The main competitors of Value Line include Abacus Life (ABL), Fidus Investment (FDUS), Diamond Hill Investment Group (DHIL), Bridge Investment Group (BRDG), Saratoga Investment (SAR), Vinci Partners Investments (VINP), Silvercrest Asset Management Group (SAMG), Monroe Capital (MRCC), Sculptor Capital Management (SCU), and ArrowMark Financial (BANX). These companies are all part of the "investment advice" industry.

Value Line vs.

Value Line (NASDAQ:VALU) and Abacus Life (NASDAQ:ABL) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Value Line has higher revenue and earnings than Abacus Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Value Line$39.49M11.13$18.07M$1.9623.78
Abacus Life$25.37M16.85-$640KN/AN/A

Value Line has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Abacus Life has a beta of -0.25, suggesting that its share price is 125% less volatile than the S&P 500.

Value Line has a net margin of 46.77% compared to Abacus Life's net margin of 0.00%. Value Line's return on equity of 22.28% beat Abacus Life's return on equity.

Company Net Margins Return on Equity Return on Assets
Value Line46.77% 22.28% 14.19%
Abacus Life N/A -35.78%-6.72%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Value Line
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Abacus Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Value Line received 175 more outperform votes than Abacus Life when rated by MarketBeat users.

CompanyUnderperformOutperform
Value LineOutperform Votes
175
61.84%
Underperform Votes
108
38.16%
Abacus LifeN/AN/A

In the previous week, Value Line had 3 more articles in the media than Abacus Life. MarketBeat recorded 3 mentions for Value Line and 0 mentions for Abacus Life. Value Line's average media sentiment score of 0.98 beat Abacus Life's score of 0.00 indicating that Value Line is being referred to more favorably in the media.

Company Overall Sentiment
Value Line Positive
Abacus Life Neutral

6.4% of Value Line shares are owned by institutional investors. Comparatively, 16.0% of Abacus Life shares are owned by institutional investors. 0.0% of Value Line shares are owned by company insiders. Comparatively, 47.0% of Abacus Life shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Value Line beats Abacus Life on 9 of the 12 factors compared between the two stocks.


Get Value Line News Delivered to You Automatically

Sign up to receive the latest news and ratings for VALU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VALU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VALU vs. The Competition

Export to Excel
MetricValue LineInvestment advice IndustryFinance SectorNASDAQ Exchange
Market Cap$439.53M$7.22B$7.15B$6.27B
Dividend Yield2.41%24.21%8.84%6.51%
P/E Ratio23.7838.8077.8112.57
Price / Sales11.134.123,586.6070.16
Price / Cash22.4723.6537.06100.49
Price / Book5.143.082.154.83
Net Income$18.07M$303.51M$720.24M$186.05M
7 Day Performance3.58%-2.80%-1.86%-3.10%
1 Month Performance-13.12%-0.32%2.00%-5.68%
1 Year Performance-0.79%12.79%4.27%5.50%

Value Line Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABL
Abacus Life
0 of 5 stars		$7.25
+1.5%		N/AN/A$456.46MN/A0.0082Positive News
Gap Up
FDUS
Fidus Investment
2.1584 of 5 stars		$18.92
+0.9%		$21.00
+11.0%		+10.0%$479.05M$94.14M11.00N/AEx-Dividend
Positive News
High Trading Volume
DHIL
Diamond Hill Investment Group
2.242 of 5 stars		$163.01
-1.6%		N/A-3.2%$479.25M$154.50M10.06129Positive News
BRDG
Bridge Investment Group
2.5062 of 5 stars		$10.02
+0.4%		$15.08
+50.5%		-37.2%$334.17M$409.05M-125.252,250Negative News
SAR
Saratoga Investment
2.0519 of 5 stars		$25.85
+0.2%		$27.10
+4.8%		+13.3%$309.68M$37.65M11.805
VINP
Vinci Partners Investments
2.6482 of 5 stars		$10.76
+1.2%		$14.00
+30.1%		-0.1%$592.66M$79.04M12.66215
SAMG
Silvercrest Asset Management Group
3.0772 of 5 stars		$17.45
+0.2%		$23.00
+31.8%		-3.1%$242.56M$123.22M14.19152Positive News
MRCC
Monroe Capital
2.1293 of 5 stars		$7.34
-0.9%		$8.00
+9.0%		-4.9%$159.06M$56.57M52.43N/ANews Coverage
SCU
Sculptor Capital Management
1.8573 of 5 stars		$11.75
flat		$13.00
+10.6%		+29.8%$736.31M$391.01M-10.04343
BANX
ArrowMark Financial
2.0303 of 5 stars		$18.33
+1.2%		N/A-0.2%$130.33M$17.36M34.59N/AUpcoming Earnings
Dividend Cut
High Trading Volume

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:VALU) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -